home / stock / ghdx / ghdx news


GHDX News and Press, Genomic Health Inc. From 02/21/19

Stock Information

Company Name: Genomic Health Inc.
Stock Symbol: GHDX
Market: NASDAQ

Menu

GHDX GHDX Quote GHDX Short GHDX News GHDX Articles GHDX Message Board
Get GHDX Alerts

News, Short Squeeze, Breakout and More Instantly...

GHDX - Genomic Health (GHDX) Investor Presentation - Slideshow

The following slide deck was published by Genomic Health, Inc. in conjunction with this Read more ...

GHDX - Genomic Health, Inc. (GHDX) CEO Kim Popovits on Q4 2018 Results - Earnings Call Transcript

Genomic Health, Inc. (GHDX) Q4 2018 Earnings Conference Call February 20, 2019 04:30 PM ET Company Participants Emily Faucette - Vice President, Corporate Communications & Investor Relations Kim Popovits - Chairman of the Board, Chief Executive Officer and President Brad Cole...

GHDX - VIPS, ALB and CAR among notable movers

Gainers: SRCI   +11.8% . CAR   +10.9% . HTZ   +7.3% . ALB   +5.7% . GHDX   +5.6% . More news on: SRC Energy Inc., Avis Budget Group, Inc., Hertz Global Holdings, Inc., Stocks on the move, Read more ...

GHDX - Genomic Health misses by $0.05, beats on revenue

Genomic Health (NASDAQ: GHDX ): Q4 GAAP EPS of $0.23 misses by $0.05 . More news on: Genomic Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

GHDX - Genomic Health Reports Record 2018 Fourth Quarter and Year-end Financial Results and Provides 2019 Financial Guidance

REDWOOD CITY, Calif. , Feb. 20, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2018 . "2018 was a record year for Genomic Health. We delivered $394.1 million in revenue a...

GHDX - Genomic Health Q4 Earnings Preview

Genomic Health (NASDAQ: GHDX ) is scheduled to announce Q4 earnings results on Wednesday, February 20th, after market close. The consensus EPS Estimate is $0.28 and the consensus Revenue Estimate is $101.55M Over the last 1 year, GHDX has beaten EPS estimates 75% of the time and has ...

GHDX - Genomic Health to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on Wednesday, February 20, 2019

REDWOOD CITY, Calif. , Feb. 13, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 20 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2018 financial results....

GHDX - Oncotype DX® Genomic Prostate Score® Established as First Genomic Test with Prospective Validation for Predicting Adverse Pathology in Newly Diagnosed Patients

REDWOOD CITY, Calif. , Feb. 5, 2019 /PRNewswire/ --  Genomic Health, Inc . (Nasdaq: GHDX) today announced the publication of results from a multi-center, prospective validation study of the Oncotype DX ® Genomic Prostate Score ® (GPS ™ ) test in newly diagnosed men...

GHDX - Smart Money Results For January 2019

After a very successful 2018, the Smart Money portfolios are off to a rip-roaring start in 2019. Table 1 is a summary of returns for each of the Smart Money strategies during January 2019. Table 1. Summary of returns for all Smart Money strategies The results for January have been outsta...

GHDX - Genomic Health Marks More than 1 Million Patients Worldwide Who Have Benefited from Oncotype DX Testing in Personalizing Cancer Treatment Decisions to Improve Outcomes

REDWOOD CITY, Calif. , Jan. 7, 2019 /PRNewswire/ --  Genomic Health, Inc.  (NASDAQ: GHDX) today announced that, in collaboration with physicians around the world, it has delivered more than 1 million Oncotype DX ® tests to cancer patients worldwide since it made its f...

Previous 10 Next 10